Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02128906
Title Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Pittsburgh

larynx cancer

hypopharynx cancer

head and neck squamous cell carcinoma

oropharynx cancer


Cetuximab + Docetaxel


Age Groups: adult
Covered Countries USA

No variant requirements are available.